
Weight-loss drugs to get surprising endorsement from global health giant
Fox News
According to Reuters, the WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic.
In a memo, the agency called for strategies to improve access to the medications in countries that are low- and middle-income, Reuters summarized. Angelica Stabile is a lifestyle reporter for Fox News Digital.
More than one billion people have obesity across the globe, according to WHO's data, and around 70% of these individuals live in low- and middle-income countries.
More Related News













